Investors often scoff at the stock's premium price tag. But if there's any business that deserves such a high valuation multiple, it's this one.

Shares of natural food company Hain Celestial (NASDAQ:HAIN) fell 5.9% in the afternoon session after Barclays downgraded the stock to Underweight from Equal Weight.

Clinical-stage biotech Dianthus Therapeutics develops antibody therapies for severe autoimmune and neuromuscular conditions.

The chief executive just provided a stunning forecast for the company's future growth.

Why are the major indexes falling today? Here is how persistent inflation and the latest Fed decision are shaping the market's move.

This Boston-based biotech develops therapies for neurological disorders, with a pipeline targeting depression, tremor, and rare epilepsies.

Deutsche Bank has identified three factors that could trigger a war-related recession.

Ten percent of The Trade Desk's business now appears to be in jeopardy.

Operating nationwide, Telephone and Data Systems delivers broadband and cloud-based services to a diverse U.S. customer base.

The S&P 500 index was licensed to Trade[XYZ], a provider of markets for real-world assets on Hyperliquid for perpetual futures.

These companies are a fantastic way to profit from a surging semiconductor industry as artificial intelligence continues to change the world.

Micron shares have soared 63% to start the year, among the best performers in the S&P 500 Index, after jumping 239% in 2025. The biggest US maker of memory chips is benefiting from heavy spending on artificial intelligence computing that’s driving demand

These AI-adjacent companies are growing at a rapid pace and have massive opportunities.

ManpowerGroup delivers workforce and talent solutions to clients in over 75 countries, spanning recruitment, training, and HR outsourcing.

Macy's shares gained after the department store chain reported quarterly profits that topped analysts' estimates and unexpected growth in its same-store sales.